FDA Drug Abuse Advisory Committee
Executive Summary
Set to meet Nov. 22 to discuss the "development of guidelines for the clinical evaluation of medications for the treatment of drug abuse." Meeting begins at 10 a.m. in the Maryland Room at the Parklawn Building in Rockville, Maryland.